BHB-1893 structure
Braveheart Bio Takes HRS-1893 (BHB-1893) Global: Structure, Patents & Race vs Aficamten and Mavacamten
Hengrui’s HRS-1893, licensed to Braveheart Bio (BHB-1893), advances in oHCM (Phase III, NCT07021976) and nHCM (Phase II), with global expansion planned for 2026. Review covers structure, patents, PK, and clinical data.